Assessment | Biopsychology | Comparative | Cognitive | Developmental | Language | Individual differences | Personality | Philosophy | Social |
Methods | Statistics | Clinical | Educational | Industrial | Professional items | World psychology |

Biological: Behavioural genetics · Evolutionary psychology · Neuroanatomy · Neurochemistry · Neuroendocrinology · Neuroscience · Psychoneuroimmunology · Physiological Psychology · Psychopharmacology (Index, Outline)

Noonan syndrome
Classification and external resources
A 12-year-old female with Noonan syndrome. Typical webbed neck. Double structural curve with rib deformity.
ICD-10 Q871
ICD-9 759.89
OMIM 163950
DiseasesDB 29094
eMedicine article/947504
MeSH D009634

Noonan Syndrome (NS) is a relatively common autosomal dominant congenital disorder considered to be a type of dwarfism, that affects both males and females equally[1]:550. It used to be referred to as the male version of Turner's syndrome[2] (and is still sometimes described in this way);[3] however, the genetic causes of Noonan syndrome and Turner syndrome are distinct. The principal features include congenital heart defect (typically pulmonary valve stenosis), short stature, learning problems, pectus excavatum, impaired blood clotting, and a characteristic configuration of facial features including a webbed neck and a flat nose bridge. The syndrome is named after Dr. Jacqueline Noonan.

It is believed that between approximately 1 in 1,000 and 1 in 2,500 children worldwide are born with NS. It is one of the most common genetic syndromes associated with congenital heart disease, similar in frequency to Down syndrome. However, the range and severity of features can vary greatly in patients with NS. Therefore, the syndrome is not always identified at an early age.

Characteristics[edit | edit source]

Often called a "hidden" condition, the person affected may have no obvious casual signs to the onlooker, but the problems may be many and complex. The most prevalent (common) signs are highlighted in bold with frequency listed in parentheses.

By organ system[edit | edit source]

Heart[edit | edit source]

2/3 of patients have one of the following heart defects

Gastrointestinal system[edit | edit source]

Genito-urinary system[edit | edit source]

Lymphatic system[edit | edit source]

  • Posterior cervical hygroma (webbed neck)
  • Lymphedema (build-up of body fluid due to poor functioning of the lymphatic system)

Developmental[edit | edit source]

Musculoskeletal[edit | edit source]

  • Some patients with Noonan Syndrome suffer from severe joint pain or muscle pain often with no identifiable cause

Hematologic[edit | edit source]

Neurological[edit | edit source]

Arnold-Chiari Malformation (Type 1) has been noted in some patients with Noonan Syndrome

By physical appearance[edit | edit source]

Stature and posture[edit | edit source]

Head[edit | edit source]

  • Excess skin on the back of the neck
  • Low hairline at the nape of the neck
  • High hairline at the front of the head
  • Large head
  • Triangular face shape
  • Broad forehead
  • Short neck, webbed neck, posterior cervical
  • Curly hair

Eyes[edit | edit source]

Nose[edit | edit source]

  • Small, upturned nose

Ears and hearing[edit | edit source]

  • Low set ears(over 90%)
  • Backward rotated ears(over 90%)
  • Thick helix of ear (outer rim) —(over 90%)
  • Incomplete folding of ears
  • Chronic Otitis media (ear infections)

Mouth and speech[edit | edit source]

  • Deeply grooved philtrum (top lip line) —(over 90%)
  • Micrognathia (undersized lower jaw)
  • High Arched palate
  • Dental problems
  • Articulation Difficulties
  • Poor tongue control

Limbs/extremities[edit | edit source]

  • Bluntly ended fingers
  • Extra padding on fingers and toes
  • Edema of the back of hands and tops of feet
  • Cubitus valgus (elbow deformity: with abnormal turning-in)

Skin[edit | edit source]

Cause[edit | edit source]


NS may be inherited in an autosomal dominant pattern with variable expression.

Recurrence in siblings and apparent transmission from parent to child has long suggested a genetic defect with autosomal dominant inheritance and variable expression. A person with NS has up to a 50% chance of transmitting it to a child. The fact that an affected parent is not always identified for children with NS suggests several possibilities:

  1. manifestations are variably expressed and could be so subtle as to go unrecognized (variable expressivity)
  2. a high proportion of cases represent new, sporadic mutations or
  3. Noonan syndrome is heterogeneous, comprising more than one similar condition of differing cause, some not inherited.
Type OMIM Gene Description
NS1 163950 PTPN11 In most of the families with multiple affected members, NS maps to chromosome 12q24.1. In 2001, it was reported that approximately half of a group of patients with Noonan syndrome carried a mutation of the PTPN11 gene at that location, which encodes protein tyrosine phosphatase SHP-2.[4] The SHP2 protein is a component of several intracellular signal transduction pathways involved in embryonic development that modulate cell division, differentiation, and migration, including that mediated by the epidermal growth factor receptor. The latter pathway is important in the formation of the cardiac semilunar valves.
Chromosomal abnormalities, such as a duplication of chromosome region 12q24 encompassing gene PTPN11 can result in an apparent Noonan syndrome.[5]
NS2 605275 unknown (autosomal recessive)[6]
NS3 609942 KRAS Additional mutations in KRAS [7] genes have been reported to cause Noonan syndrome in a smaller percentage of individuals with the syndrome.
NS4 610733 SOS1 It has recently been shown that activating mutations in SOS1 also give rise to NS.[8] Shp2 and SOS1 both have roles as positive regulators of the Ras/MAP kinase pathway suggesting that dysregulation of this pathway may play a major role in the genesis of this syndrome.[9]
NS5 611553 RAF1 Additional mutations in RAF1[10] genes have been reported to cause Noonan syndrome in a smaller percentage of individuals with the syndrome.

A condition known as "neurofibromatosis-Noonan syndrome" is associated with neurofibromin.[11]

Diagnosis[edit | edit source]

Despite identification of four causative genes, the diagnosis of Noonan syndrome is still based on clinical features. In other words, it is made when a physician feels that a patient has enough of the features to warrant the label indicating association. The patient can be screened for mutations in the PTPN11, SOS1, or KRAS genes, however absence of a mutation will not exclude the diagnosis as there are more as yet undiscovered genes that cause NS. The principal values of making such a diagnosis are that it guides additional medical and developmental evaluations, it excludes other possible explanations for the features, and it allows more accurate recurrence risk estimates.

History[edit | edit source]


The oldest known case of Noonan syndrome, described in 1883 by Kobylinski.

Jacqueline Noonan was practicing as a pediatric cardiologist at the University of Iowa when she noticed that children with a rare type of heart defect, valvular pulmonary stenosis, often had a characteristic physical appearance with short stature, webbed neck, wide spaced eyes, and low-set ears. Both boys and girls were affected. Even though these characteristics were sometimes seen running in families, chromosomes appeared grossly normal. She studied 833 patients at the congenital heart disease clinic, looking for other congenital abnormalities, and in 1962 presented a paper: "Associated non-cardiac malformations in children with congenital heart disease". This described 9 children who in addition to congenital heart disease had characteristic faces, chest deformities and short stature. Both males and females were found to be similarly affected, and the chromosomes were apparently normal.

Dr. John Opitz, a former student of Dr. Noonan, first began to call the condition "Noonan Syndrome" when he saw children who looked like those whom Dr. Noonan had described. Dr. Noonan later produced a paper entitled "Hypertelorism with Turner Phenotype", and in 1971 at the Symposium of Cardiovascular defects, the name 'Noonan Syndrome' became officially recognized.

See also[edit | edit source]

  • Turner syndrome — a different disorder which is often confused with Noonan syndrome because of several physical features that they have in common.
  • Fetal alcohol syndrome — another disorder that is sometimes confused with Noonan syndrome because of some common facial features and mental retardation[12]
  • Leopard syndrome— A related disorder caused by mutations in PTPN11 that are catalytically inactivating.
  • Cardiofaciocutaneous syndrome — A related disorder which also affects genes encoding elements of the Ras/MAP kinase pathway.
  • Dermatoglyphics

References[edit | edit source]

  1. James, William; Berger, Timothy; Elston, Dirk (2005). Andrews' Diseases of the Skin: Clinical Dermatology. (10th ed.). Saunders. ISBN 0-7216-2921-0.
  2. Curcić-Stojković O, Nikolić L, Obradović D, Krstić A, Radić A (1978). [Noonan's syndrome. (Male Turner's syndrome, Turner-like syndrome)]. Med Pregl 31 (7–8): 299–303.
  3. Template:DorlandsDict
  4. Tartaglia M, Mehler EL, Goldberg R, et al (2001). Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat. Genet. 29 (4): 465–8.
  5. Shchelochkov OA et al, Am J Med Genet A, 2008 Apr 15;146A(8):1042-8
  6. PMID 10982482 (PMID 10982482)
    Citation will be completed automatically in a few minutes. Jump the queue or expand by hand
  7. Schubbert S, Zenker M, Rowe SL, et al (2006). Germline KRAS mutations cause Noonan syndrome. Nat. Genet. 38 (3): 331–6.
  8. Roberts AE, Araki T, Swanson KD, et al (2007). Germline gain-of-function mutations in SOS1 cause Noonan syndrome. Nat. Genet. 39 (1): 70–4.
  9. Bentires-Alj M, Kontaridis MI, Neel BG (2006). Stops along the RAS pathway in human genetic disease. Nat. Med. 12 (3): 283–5.
  10. Razzaque MA, Nishizawa T, Komoike Y, et al (2007). Germline gain-of-function mutations in RAF1 cause Noonan syndrome. Nat. Genet. 39 (8): 1013–7.
  11. PMID 16380919 (PMID 16380919)
    Citation will be completed automatically in a few minutes. Jump the queue or expand by hand
  12. CDC. (2004). Fetal Alcohol Syndrome: Guidelines for Referral and Diagnosis. Can be downloaded at

External links[edit | edit source]

Template:Phakomatoses and other congenital malformations not elsewhere classified Template:Deficiencies of intracellular signaling peptides and proteins

This page uses Creative Commons Licensed content from Wikipedia (view authors).
Community content is available under CC-BY-SA unless otherwise noted.